Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Arthritis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Arthritis Other
    Zoledronic Acid Better for Bone Remodelling Than Risedronate in Glucocorticoid-Induced Osteoporosis: Presented at EULAR - (DGDispatch)
    Adalimumab Demonstrates Long-Term Benefit in Ankylosing Spondylitis: Presented at EULAR - (DGDispatch)
    Infliximab Monotherapy Effective for Long-Term Treatment of Spondyloarthritis: Presented at EULAR - (DGDispatch)
    Malignancies in Etanercept-Treated Patients Uncommon: Presented at EULAR - (DGDispatch)
    Teriparatide Tops Alendronate in Multiple Subgroups at Increased Fracture Risk: Presented at EULAR - (DGDispatch)

    News archive

     Recent webcasts/CME - Arthritis Other
    • Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
    • Long-Term Data on Abatacept and Rituximab Show Continued Efficacy in Rheumatoid Arthritis
    • Are Rituximab and Abatacept Safe Over the Long Term in Rheumatoid Arthritis?
    • Inflammatory Arthritis -The Antisynthetase Syndrome
      Inflammatory Arthritis - Gout

      Webcasts/CME archive

       Recent cases - Arthritis Other
        Fever and Skin Redness in a 10-Year-Old Boy
        Bilateral Sternoclavicular Joint Septic Arthritis Secondary to Indwelling Central Venous Catheter: A Case Report
        Bowel Associated Dermatosis - Arthritis Syndrome: A Case Report
        Streptobacillus Moniliformis Septic Arthritis: A Clinical Entity Distinct from Rat-Bite Fever?
        Reactive Arthritis of the Temporomandibular Joints and Cervical Spine in a Child

        Cases archive
          




        my personal edition > arthritis other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Rheumatoid Arthritis Drug, Leflunomide, May Aid Resistant Psoriatic Arthritis

        A DGReview of :"Open Trial of Leflunomide for Refractory Psoriasis and Psoriatic Arthritis"
        JCR: Journal of Clinical Rheumatology

        01/09/2002
        By Anne MacLennan


        A drug recently approved for the treatment of rheumatoid arthritis may prove to be a useful agent for recalcitrant cases of psoriasis and psoriatic arthritis.

        Until now, the role of leflunomide in the treatment of psoriasis and psoriatic arthritis has not been clarified, although the drug is indicated for rheumatoid arthritis treatment.

        Participants in this study were 12 consecutive psoriatic arthritis patients who had not responded to at least one disease modifying anti-rheumatic drug (DMARD). All of the patients were started on leflunomide alone or in combination with another DMARD.

        Global assessment of improvement in psoriasis and psoriatic arthritis by the treating rheumatologist was scored on a zero-to-three scale.

        Doctors found that after two to three months of treatment, eight of the patients had moderate to marked improvement in both psoriasis and psoriatic arthritis.

        The improvement in modified tender joint counts, patient's global assessments and grip strengths was found to be statistically significant. The doctors' global assessments and the modified swollen joint counts, however, did not reach a significant difference.

        Three patients whose toxicity necessitated the temporary discontinuation of the drug were able to resume the drug at lower dosage with clinical benefit.

        Thus, leflunomide may prove to be useful for the treatment of recalcitrant cases of psoriasis and psoriatic arthritis, these authors conclude.

        This clinical study was undertaken by George C. Liang and Walter G. Barr from the Division of Rheumatology, Department of Medicine, Northwestern University Medical School, Chicago, Illinois.
        JCR: Journal of Clinical Rheumatology 2001;7:366-370. "Open Trial of Leflunomide for Refractory Psoriasis and Psoriatic Arthritis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send